ASIA unversity:Item 310904400/81153
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90437/105768 (86%)
Visitors : 10939989      Online Users : 626
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/81153


    Title: CCT327 enhances TRAIL-induced apoptosis through the induction of death receptors and downregulation of cel lsurvival proteins in TRAIL-resistant human leukemia cells
    Authors: LIU, YAN-JIN;LIU, YAN-JIN;YING-CHAO, LI;LIN, YING-CHAO;JANG-CHANG, L;LEE, JANG-CHANG;SHENG-CHU, KU;KUO, SHENG-CHU;CHI-TANG, HO;CHI-TANG, HO;HUAN, LI-JIAU;HUANG, LI-JIAU;DAIH-HUANG, K;KUO, DAIH-HUANG;魏宗德;Way, Tzong-Der;*
    Contributors: 保健營養生技學系
    Date: 2014-05
    Issue Date: 2014-10-01 16:47:07 (UTC+8)
    Abstract: Tumor necrosis factor-related apoptosis‑inducing ligand (TRAIL) has potential application in cancer therapy and it has the ability to selectively kill cancer cells without affecting normal cells. However, the development of resistance to TRAIL in cancer cells cannot be avoided. This study investigated the effects of 2-(5-methylselenophen‑2‑yl)‑6,7‑methylenedioxyquinolin‑4-one (CCT327), an analogue of quinolin-4-one, on the sensitization of cancer cells to TRAIL and on TRAIL‑induced apoptosis in TRAIL‑resistance human leukemia cells (HL60‑TR). We found that CCT327 enhanced TRAIL‑induced apoptosis through upregulation of death receptors DR4 and DR5. In addition to upregulating DRs (death receptors), CCT327 suppressed the expression of decoy receptor DcR1 and DcR2. CCT327 significantly downregulated the expression of FLICE inhibitory protein (cFLIP) and other antiapoptotic proteins. We also demonstrated that CCT327 could activate p38 and JNK. Moreover, CCT327-induced induction of DR5 and DR4 was mediated by reactive oxygen species (ROS), and N-acetylcysteine (NAC) blocked the induction of DRs by CCT327. Taken together, these results showed that CCT327 combined with TRAIL treatment may provide an effective therapeutic strategy for cancer.
    Relation: ONCOLOGY REPORTS; 32(3):1257-64.
    Appears in Collections:[Department of Food Nutrition and Healthy Biotechnology] Journal Article

    Files in This Item:

    File SizeFormat
    index.html0KbHTML137View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback